Please check your internet connection and try again.
# Isoxsuprine hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator. Its exact mechanism of action is not fully understood but it is thought to relax vascular smooth muscle, leading to vasodilation and improved blood flow.
## Primary Indications
* Treatment of peripheral vascular diseases, such as intermittent claudication and Raynaud's phenomenon, to improve blood flow to the extremities.
* To promote wound healing in patients with vascular insufficiency.
## Adult Dosing
* **Intermittent Claudication:** 10-20 mg three to four times daily.
* **Peripheral Vascular Diseases:** 10-20 mg three to four times daily.
* Dosage may be increased gradually as tolerated. The maximum daily dose is generally considered to be 80 mg.
## Pediatric Dosing
There is no established pediatric dosing for isoxsuprine hydrochloride. Its use in children is generally not recommended due to a lack of safety and efficacy data.
## Dose Adjustments
* No specific dose adjustments are routinely recommended for renal or hepatic impairment, but caution and careful monitoring are advised due to limited data.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Use in patients with congenital heart disease or arrhythmias.
* Should not be administered immediately postpartum or in the presence of significant hypotension.
## Adverse Effects
Common adverse effects include:
* Nausea, vomiting, gastrointestinal distress
* Dizziness, lightheadedness
* Weakness, flushing
* Hypotension
* Palpitations, tachycardia
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications.
* **Sympathomimetic agents:** May increase cardiovascular stimulation.
## Monitoring
* Blood pressure and heart rate should be monitored regularly, especially at the initiation of therapy and with dose increases, due to the risk of hypotension and tachycardia.
* Monitor for signs and symptoms of peripheral vascular disease improvement (e.g., decreased pain, improved wound healing).
## Clinical Pearls
* Isoxsuprine is typically administered orally.
* Effectiveness may take several weeks to become apparent.
* Patients should be advised to report any new or worsening cardiovascular symptoms to their healthcare provider.
* This medication is not a substitute for wound care or management of underlying conditions contributing to vascular insufficiency.
***
**Disclaimer:** This information is intended for healthcare professionals and does not substitute for professional medical advice. Always consult the most current prescribing information and clinical guidelines for specific patient management decisions. The availability and approved indications for drugs may vary by region.
